seo-company

Palladio Biosciences, Inc., a Centessa company

Palladio Biosciences, Inc., is a Centessa company. Our first product, lixivaptan, is in Phase 3 clinical development for the treatment of autosomal polycystic kidney disease (ADPKD). ADPKD causes num...load more


Palladio Biosciences, Inc., a Centessa company's Basic Information

Industry
Headquarters
Horsham, Pennsylvania, United States
Founded Year
2015
Headcount
Specialties
Renal DiseaseKidney DiseasePolycystic Kidney DiseasePKDADPKDARPKDNephrologyOrphanRareGenetic Disease

Palladio Biosciences, Inc., a Centessa company's Competitors

Employee Insights

Employee Function
Employee Location

Palladio Biosciences, Inc., a Centessa company's Top Employees

people

Neil Shusterman, MD

Chief Medical Officer

Phone Email

people

Anita Fauchier

Vice President, Regulatory Affairs

Phone Email

people

Milena Kanova

Vice President Clinical Operations

Phone Email

people

Elaine R.

Vice President Clinical Operations, Palladio Biosciences

Phone Email

Find Your Next Customer with Better Data

Get access to over 120 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.

Top-ranked on G2 Crowd

GDPR compliantCancel anytime

Free credits every month!

Frequently Asked Questions Regarding Palladio Biosciences, Inc., a Centessa company

Where is Palladio Biosciences, Inc., a Centessa company's headquarter located?
Palladio Biosciences, Inc., a Centessa company's headquarter are located at United States.
How many employees does Palladio Biosciences, Inc., a Centessa company have?
Palladio Biosciences, Inc., a Centessa company has 2 - 10 employees.
What is Palladio Biosciences, Inc., a Centessa company's official website?
Palladio Biosciences, Inc., a Centessa company's official website is http://palladiobio.com
What does Palladio Biosciences, Inc., a Centessa company do?
Palladio Biosciences, Inc., is a Centessa company. Our first product, lixivaptan, is in Phase 3 clinical development for the treatment of autosomal polycystic kidney disease (ADPKD). ADPKD causes num...
What specialty does Palladio Biosciences, Inc., a Centessa company have?
Renal DiseaseKidney DiseasePolycystic Kidney DiseasePKDADPKDARPKDNephrologyOrphanRareGenetic Disease
Find Leads in 1 Click

Connect with anyone with AroundDeal today!

Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.

✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts